News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets largely unchanged this hour amid absence of major headlines, keeping equity futures flat.
  • US Treasury yields little changed, leaving bond markets subdued.
  • Oil prices quiet with minimal movement as traders await catalysts.
  • Dollar index steady against majors as risk appetite pauses.
  • Volatility measures tick lower, reflecting muted trading and low headline flow.
  • No major political or economic announcements in the past hour to move markets.

Latest Articles

ELVN-001 Could Reset CML Sequencing — A Long Trade with Defined Risk

ELVN-001 Could Reset CML Sequencing — A Long Trade with Defined Risk

Enliven Therapeutics (ELVN) has priced a high-conviction growth story into a $4.4B market cap: ELVN-001 is a clean, active-site BCR-ABL kinase inhibitor that, if confirmed in later-stage data, can change chronic myeloid leukemia (CML) sequencing. The stock trades near $59.78 with a heavy short-interest backdrop and supportive technicals. This trade…

ServiceNow Shares Jump as Analyst Upgrades and Sector Sentiment Lift Stock

ServiceNow Shares Jump as Analyst Upgrades and Sector Sentiment Lift Stock

ServiceNow shares climbed sharply in morning trading, rallying more than 6% to $145.08 as the enterprise software group recovers and recent analyst upgrades continue to underpin the stock. The move extends a rebound from the name’s 52-week low and follows positive commentary at a major technology conference, where the company highlighted its AI-dri…

SpaceX Shares Climb After Bullish Analyst Calls and Starship Filing

SpaceX Shares Climb After Bullish Analyst Calls and Starship Filing

Space Exploration Technologies Corp. shares rose roughly 3.5% in morning trading, driven by two prominent analyst actions projecting large AI-related revenue gains and a regulatory filing targeting a September 15 Starship Flight 14 orbital attempt that would carry new Starlink V3 satellites. A favorable broader market backdrop for growth names help…

Final Opportunity to Own a New Luxury Home in Toll Brothers at Tesoro Highlands - Alta Monte Collection in Valencia, California

Final Opportunity to Own a New Luxury Home in Toll Brothers at Tesoro Highlands - Alta Monte Collection in Valencia, California

Toll Brothers announced the last home available for sale in their luxury Alta Monte Collection at Tesoro Highlands, a gated community in Valencia, California. The remaining home is a spacious, move-in ready Arpina model priced from $1.9 million. The community offers premium amenities and convenient access to local attractions and transit. Toll Brot…

Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States

Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States

Milestone Pharmaceuticals announced that China's NMPA has approved etripamil nasal spray (CARDAMYST®) for treating paroxysmal supraventricular tachycardia (PSVT) in adults, marking the first approval of the drug outside the US. This approval triggers a $2 million milestone payment to Milestone and opens the door for commercialization in Greater Chi…

Alphabet 2026: AI Is the Fuel — Time to Take a Position

Alphabet 2026: AI Is the Fuel — Time to Take a Position

Alphabet is trading at a reasonable multiple while its businesses - led by Google Cloud and advertising - are benefitting from a large, accelerating AI spend cycle. This trade idea buys a near-term pullback and holds into the next leg of AI monetization: entry $342.05, stop $318.00, target $400.00 over a position horizon (180 trading days).

CN Reports August Grain Movement

CN Reports August Grain Movement

CN announced a new monthly record in grain movement across its network in August 2026, transporting 2.50 million metric tonnes of grain from Western Canada, surpassing the previous record from August 2020. This reflects strong demand and operational execution, signaling a robust start to the 2026-27 crop year and emphasizing CN's role in supporting…

Wellchange Holdings Company Limited Announces 1-for-5 Reverse Stock Split Effective September 8, 2026

Wellchange Holdings Company Limited Announces 1-for-5 Reverse Stock Split Effective September 8, 2026

Wellchange Holdings Company Limited will execute a 1-for-5 reverse stock split on its Class A ordinary shares effective September 8, 2026. The reverse split will reduce the number of outstanding shares from approximately 52.9 million to about 10.6 million, with shares continuing to trade on Nasdaq under the ticker WCT. The split is intended to cons…

Cosmos Health: A Company Transformed

Cosmos Health: A Company Transformed

Cosmos Health Inc. (NASDAQ: COSM) delivered consecutive record revenue quarters in 2026 with a strong balance sheet and significant operational milestones. The company retired $8M convertible debt early, repurchased over 5 million shares, expanded their UK retail presence including Tesco and Superdrug, entered the Saudi Arabian and other Middle Eas…

Tyson Foods Cuts Fiscal 2026 Outlook, Shares Drop as Beef Losses Widen

Tyson Foods Cuts Fiscal 2026 Outlook, Shares Drop as Beef Losses Widen

Tyson Foods lowered its fiscal 2026 adjusted operating income guidance and trimmed revenue growth expectations in a pre-market update, citing substantial margin compression tied to volatile cattle prices and a severe U.S. cattle shortage. The company also widened its projected Beef segment operating loss significantly, prompting a sharp pre-open de…

Aptevo Shares Drop Sharply Despite Strong TP53 AML Trial Readout

Aptevo Shares Drop Sharply Despite Strong TP53 AML Trial Readout

Aptevo Therapeutics shares plunged in pre-market trading despite the company reporting a high clinical benefit rate from its mipletamig triplet regimen in frontline acute myeloid leukemia patients with TP53 mutations. The decline reflects a 'sell the news' reaction, a large potential share overhang from recent financings, and persistent bearish tec…